HIV/CVD Podcast Series

Six-Part Podcast Series on the association between HIV and CVD
An estimated 1.1 million adults and adolescents in the US are infected with human immunodeficiency virus (HIV)1? The introduction of the highly-active anti-retroviral therapy (HAART) era in the 1990s revolutionized the management of the disease, giving patients the potential of living a nearly normal lifespan.

However, with this longer lifespan comes a growing understanding of the effects of the virus on organ systems beyond the immune system. By 2030, it is estimated that 73% of individuals with HIV will be 50 years or older2, and studies find that cardiovascular disease (CVD) is responsible for approximately 11% of deaths among HIV-positive patients3, a percentage that will increase as patients live longer with the disease.

Now Available:


This podcast series is supported through an educational grant from Gilead Sciences.

1. Centers for Disease Control and Prevention. HIV/AIDS. https://www.cdc.gov/hiv/statistics/overview/index.html, May 17, 2017.
2. Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810-818.
3. Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. The Lancet. 2014;384(9939):241-248.